Efficacy and Safety of Eslicarbazepine Acetate as Therapy for Patients With Painful Diabetic Neuropathy
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The primary objective of the study is to assess the efficacy of eslicarbazepine acetate (ESL)
as therapy for patients with painful diabetic neuropathy.